Patents by Inventor Detlef Gabel

Detlef Gabel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • OPHTHALMIC DYE
    Publication number: 20230310661
    Abstract: The present invention relates to the field of medicine, specifically to ophthalmic surgery, more specifically to a novel ophthalmic dye for surgery which does not stain living cells.
    Type: Application
    Filed: August 26, 2021
    Publication date: October 5, 2023
    Applicant: Vitreq B.V.
    Inventors: Detlef Gabel, Frank Ruseler
  • OPHTHALMIC DYE COMPOSITION
    Publication number: 20210213144
    Abstract: The present invention relates to the field of medicine, specifically to ophthalmic surgery, more specifically to an improved staining composition for ophthalmic surgery with low toxicity and increased staining efficiency.
    Type: Application
    Filed: April 21, 2017
    Publication date: July 15, 2021
    Applicant: VITREQ B.V.
    Inventors: Detlef GABEL, Andreas Matthias MOHR, Frank RUSELER
  • Boron containing compounds and their preparation and use in neutron capture therapy
    Patent number: 5144026
    Abstract: The present invention pertains to boron containing thiouracil derivatives, their method of preparations, and their use in the therapy of malignant melanoma using boron neutron capture therapy.
    Type: Grant
    Filed: February 4, 1992
    Date of Patent: September 1, 1992
    Assignee: The United States of America as represented by the United States Department of Energy
    Inventor: Detlef Gabel
  • Boron containing compounds and their preparation and use in neutron capture therapy
    Patent number: 5116980
    Abstract: The present invention pertains to boron containing thiouracil derivatives, their method of preparations, and their use in the therapy of malignant melanoma using boron neutron capture therapy.
    Type: Grant
    Filed: February 25, 1991
    Date of Patent: May 26, 1992
    Assignee: The United States of America as represented by the United States Department of Energy
    Inventor: Detlef Gabel
  • Thiourea derivatives, methods of their preparation and their use in neutron capture therapy of malignant melanoma
    Patent number: 5021572
    Abstract: The present invention pertains to boron containing thiouracil derivatives, their method of preparations, and their use in the therapy of malignant melanoma using boron neutron capture therapy.
    Type: Grant
    Filed: January 27, 1989
    Date of Patent: June 4, 1991
    Assignee: The United States Department of Energy
    Inventor: Detlef Gabel
  • Porphyrins for boron neutron capture therapy
    Patent number: 4959356
    Abstract: Novel compounds for treatment of brain tumors in Boron Neutron Capture Therapy are disclosed. A method for preparing the compounds as well as pharmaceutical compositions containing said compounds are also disclosed. The compounds are water soluble, non-toxic and non-labile boronated porphyrins which show significant uptake and retention in tumors.
    Type: Grant
    Filed: May 26, 1989
    Date of Patent: September 25, 1990
    Assignee: The United States of America as represented by the United States Department of Energy
    Inventors: Michiko Miura, Detlef Gabel